MIIM
FOLD

Mesirow Institutional Investment Management’s Amicus Therapeutics FOLD Stock Holding History

Mesirow Institutional Investment Management’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$842K Buy
89,382
+7,630
+9% +$79.3K 0.06% 117
2024
Q3 		$873K Buy
81,752
+43,974
+116% +$479K 0.07% 117
2024
Q2 		$375K Buy
37,778
+6,179
+20% +$63.4K 0.03% 119
2024
Q1 		$372K Buy
+31,599
New +$404K 0.03% 115

Other funds holding FOLD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Mesirow Institutional Investment Management's FOLD Position: Q4 2024 in Review

Mesirow Institutional Investment Management increased its Amicus Therapeutics (FOLD) stake by 9.3% in Q4 2024, buying an estimated $79.3K and bringing the position to 89,382 shares worth $842K. The position accounts for 0.06% of the portfolio, ranked #117.

Mesirow Institutional Investment Management first reported a position in FOLD in Q1 2024 and has held it in 4 quarters since. The position peaked at $873K in Q3 2024. 290 funds tracked by Wall St. Rank hold FOLD as of Q4 2024.

  • Mesirow Institutional Investment Management held 89,382 shares of Amicus Therapeutics worth $842K as of Q4 2024.
  • Mesirow Institutional Investment Management bought 7,630 Amicus Therapeutics shares in Q4 2024, an estimated $79.3K.
  • Amicus Therapeutics made up 0.06% of Mesirow Institutional Investment Management's portfolio in Q4 2024, its #117 holding.
  • Mesirow Institutional Investment Management first reported a position in Amicus Therapeutics in Q1 2024 and has held it in 4 quarters since.
  • Mesirow Institutional Investment Management's Amicus Therapeutics position peaked at $873K in Q3 2024.
  • 290 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q4 2024.

Based on Mesirow Institutional Investment Management's 13F filing for Q4 2024, filed 13 Feb 2025.